Imbio signs Heart&Lung Health in U.K.

By The Science Advisory Board staff writers

April 6, 2021 -- Artificial intelligence (AI) software developer Imbio has signed a deal with U.K. cardiothoracic radiology services provider Heart&Lung Health.

In a statement from Imbio, Heart&Lung Health said it would use Imbio's AI quantitative imaging algorithms in routine practice to augment reporting of computed tomography (CT) thorax studies in patients with potential lung diseases. Specifically, the software will be utilized to identify lung and cardiac conditions, according to Imbio.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.